Dissecting direct reprogramming through integrative genomic analysis (original) (raw)

Nature volume 454, pages 49–55 (2008)Cite this article

A Corrigendum to this article was published on 07 August 2008

Abstract

Somatic cells can be reprogrammed to a pluripotent state through the ectopic expression of defined transcription factors. Understanding the mechanism and kinetics of this transformation may shed light on the nature of developmental potency and suggest strategies with improved efficiency or safety. Here we report an integrative genomic analysis of reprogramming of mouse fibroblasts and B lymphocytes. Lineage-committed cells show a complex response to the ectopic expression involving induction of genes downstream of individual reprogramming factors. Fully reprogrammed cells show gene expression and epigenetic states that are highly similar to embryonic stem cells. In contrast, stable partially reprogrammed cell lines show reactivation of a distinctive subset of stem-cell-related genes, incomplete repression of lineage-specifying transcription factors, and DNA hypermethylation at pluripotency-related loci. These observations suggest that some cells may become trapped in partially reprogrammed states owing to incomplete repression of transcription factors, and that DNA de-methylation is an inefficient step in the transition to pluripotency. We demonstrate that RNA inhibition of transcription factors can facilitate reprogramming, and that treatment with DNA methyltransferase inhibitors can improve the overall efficiency of the reprogramming process.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Accession codes

Primary accessions

Gene Expression Omnibus

Data deposits

All analysed data sets can be obtained from http://www.broad.mit.edu/seq_platform/chip/. Microarray and sequence data have been submitted to the NCBI GEO database under accession numbers GSE10871 and GSE11074, respectively.

References

  1. Aoi, T. et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science doi: 10.1126/science.1154884 (2008)
  2. Maherali N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cells 1, 55–77 (2007)
    Article Google Scholar
  3. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnol. 26, 101–106 (2008)
    Article CAS Google Scholar
  4. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007)
    Article ADS CAS Google Scholar
  5. Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008)
    Article ADS CAS Google Scholar
  6. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007)
    Article CAS Google Scholar
  7. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006)
    Article CAS Google Scholar
  8. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007)
    Article ADS CAS Google Scholar
  9. Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324 (2007)
    Article ADS CAS Google Scholar
  10. Yamanaka, S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cells 1, 39–49 (2007)
    Article CAS Google Scholar
  11. Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567–582 (2008)
    Article CAS Google Scholar
  12. Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nature Biotechnol. 25, 1177–1181 (2007)
    Article CAS Google Scholar
  13. Brambrink, T. et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2, 151–159 (2008)
    Article CAS Google Scholar
  14. Stadtfeld, M. et al. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230–240 (2008)
    Article CAS Google Scholar
  15. Hanna, J. et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133, 250–264 (2008)
    Article CAS Google Scholar
  16. Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nature Rev. Mol. Cell Biol. 6, 635–645 (2005)
    Article CAS Google Scholar
  17. Rowland, B. D. & Peeper, D. S. KLF4, p21 and context-dependent opposing forces in cancer. Nature Rev. Cancer 6, 11–23 (2006)
    Article CAS Google Scholar
  18. Gregory, M. A., Qi, Y. & Hann S. R The ARF tumor suppressor: keeping Myc on a leash. Cell Cycle 4, 249–252 (2005)
    Article CAS Google Scholar
  19. Rideout, W. M. et al. Generation of mice from wild-type and targeted ES cells by nuclear cloning. Nature Genet. 24, 109–110 (2000)
    Article CAS Google Scholar
  20. Lowry, W. E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl Acad. Sci. USA 105, 2883–2888 (2008)
    Article ADS CAS Google Scholar
  21. Orford, K. W. & Scadden, D. T. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nature Rev. Genet. 9, 115–128 (2008)
    Article CAS Google Scholar
  22. Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553–560 (2007)
    Article ADS CAS Google Scholar
  23. Imamura, M. et al. Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Dev. Biol. 6, 34 (2006)
    Article Google Scholar
  24. Silva, J. & Smith, A. Capturing pluripotency. Cell 132, 532–536 (2008)
    Article CAS Google Scholar
  25. Lim, L. S. et al. Zic3 is required for maintenance of pluripotency in embryonic stem cells. Mol. Biol. Cell 18, 1348–1358 (2007)
    Article CAS Google Scholar
  26. Bernstein, B. E., Meissner, A. & Lander, E. S. The mammalian epigenome. Cell 128, 669–681 (2007)
    Article CAS Google Scholar
  27. Jackson-Grusby, L. et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nature Genet. 27, 31–39 (2001)
    Article CAS Google Scholar
  28. Lei, H. et al. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122, 3195–3205 (1996)
    CAS PubMed Google Scholar
  29. Meissner, A. et al. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. 33, 5868–5877 (2005)
    Article CAS Google Scholar
  30. Hajkova, P. et al. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 452, 877–881 (2008)
    Article ADS CAS Google Scholar
  31. Singh, A. M. et al. A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem Cells 25, 2534–2542 (2007)
    Article CAS Google Scholar
  32. Meissner, A. et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (in the press)
  33. Beard, C. et al. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 44, 23–28 (2006)
    Article CAS Google Scholar

Download references

Acknowledgements

We thank the staff of the Broad Institute Genome Sequencing Platform, Genetic Analysis Platform and RNAi Platform for assistance with reagents and data generation. This research was supported by funds from the National Institutes of Health, the National Human Genome Research Institute, the National Cancer Institute, and the Broad Institute of MIT and Harvard.

Author information

Authors and Affiliations

  1. Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA ,
    Tarjei S. Mikkelsen, Xiaolan Zhang, Bradley E. Bernstein, Eric S. Lander & Alexander Meissner
  2. Division of Health Sciences and Technology,,
    Tarjei S. Mikkelsen
  3. Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,
    Rudolf Jaenisch & Eric S. Lander
  4. Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA ,
    Jacob Hanna, Marius Wernig, Patrick Schorderet, Rudolf Jaenisch & Eric S. Lander
  5. Molecular Pathology Unit and Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA ,
    Manching Ku & Bradley E. Bernstein
  6. Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA,
    Bradley E. Bernstein
  7. Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02114, USA,
    Eric S. Lander
  8. Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA,
    Alexander Meissner

Authors

  1. Tarjei S. Mikkelsen
    You can also search for this author inPubMed Google Scholar
  2. Jacob Hanna
    You can also search for this author inPubMed Google Scholar
  3. Xiaolan Zhang
    You can also search for this author inPubMed Google Scholar
  4. Manching Ku
    You can also search for this author inPubMed Google Scholar
  5. Marius Wernig
    You can also search for this author inPubMed Google Scholar
  6. Patrick Schorderet
    You can also search for this author inPubMed Google Scholar
  7. Bradley E. Bernstein
    You can also search for this author inPubMed Google Scholar
  8. Rudolf Jaenisch
    You can also search for this author inPubMed Google Scholar
  9. Eric S. Lander
    You can also search for this author inPubMed Google Scholar
  10. Alexander Meissner
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toAlexander Meissner.

Supplementary information

Supplementary information

The file contains Supplementary Figures S1-S15 with Legends. (PDF 10919 kb)

Supplementary information

The file contains Supplementary Data S1 with all microarray data analyzed in the manuscript (RMA normalized and post-processed). (XLS 13923 kb)

Supplementary information

The file contains Supplementary Data S2 with positions, CpG classifications and chromatin states for all promoters analyzed in the manuscript. (XLS 3872 kb)

Rights and permissions

About this article

Cite this article

Mikkelsen, T., Hanna, J., Zhang, X. et al. Dissecting direct reprogramming through integrative genomic analysis.Nature 454, 49–55 (2008). https://doi.org/10.1038/nature07056

Download citation

Editorial Summary

Stem cells: Genomic analysis of pluripotency

The ability to persuade fully differentiated (somatic) human cells into a pluripotent stem cell state reliably would be a great advance in regenerative medicine. Recent work in human and mouse cells showed that such reprogramming is possible, but current routes to iPS (induced pluripotent stem) cells are inefficient and the mechanisms involved are poorly understood. Now a genomic analysis of the reprogramming of murine fibroblasts and B lymphocytes, together with an analysis of the chromatin state and DNA methylation, throws light on the obstacles that prevent most cells from reprogramming. It seems that some cells become trapped in partially reprogrammed states due to incomplete repression of transcription factors, that transient RNA inhibition of transcription factors can aid reprogramming, and that treatment with DNA methyltransferase inhibitors can improve the efficiency of the reprogramming process.

Associated content